Physician profile
Ross Jones
NPI 1083856041
$1,084.20
in general payments reported to CMS, 2019-2025
17 companies · $63.26 in 2025
The $63.26 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $109 · 2021: $136 · 2022: $240 · 2023: $199 · 2024: $58.08 · 2025: $63.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.89 | 2019-2025 | |
| Boston Scientific Corporation | $228.98 | 2019-2024 | Endoarmor, Autotome Rx 49 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.17 | 2019-2023 | Xifaxan, Uceris, Trulance |
| Gilead Sciences, INC. | $100.85 | 2019-2023 | |
| Janssen Biotech, INC. | $67.59 | 2019-2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $51.62 | 2019-2023 | Entyvio |
| Merck Sharp & Dohme LLC | $30.77 | 2019-2022 | |
| Daiichi Sankyo INC. | $18.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.55 | 2023 | Cyltezo |
| Braintree Laboratories, INC. | $15.36 | 2022 | |
| Echosens North America, INC. | $14.65 | 2021 | |
| Genzyme Corporation | $13.95 | 2023 | |
| Organon LLC | $13.88 | 2022 | |
| Redhill Biopharma INC. | $13.82 | 2020 | |
| Intercept Pharmaceuticals, INC. | $13.78 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $13.57 | 2019 | |
| Celgene Corporation | $12.96 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.